Genetic characterization of simian foamy viruses infecting humans

Journal of Virology

Volumn 86, Issue 24, 2012, Pages 13350-13359

  Rua, Réjane ^a,b,c   Betsem, Edouard ^a,b,d   Calattini, Sara ^a,b,f   Saib, Ali ^e   Gessaina, Antoine ^a,b  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^e Bioinformatique et Chimie Moléculaire   (France)

^f CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BET GENE; CELL STRAIN BHK; CHIMPANZEE; COCULTURE; CONTROLLED STUDY; DNA SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GORILLA; GROUP SPECIFIC ANTIGEN GENE; HAPLORHINI; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RETROVIRUS INFECTION; SEQUENCE ANALYSIS; SIMIAN FOAMY VIRUS; TAS GENE; VIRUS GENE; VIRUS GENOME; VIRUS REPLICATION; VIRUS STRAIN; ZOONOSIS;

ANIMALS; BASE SEQUENCE; CAMEROON; DNA, VIRAL; GENES, VIRAL; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMORPHISM, GENETIC; PRIMATES; SEQUENCE HOMOLOGY, NUCLEIC ACID; SIMIAN FOAMY VIRUS; VIRUS REPLICATION;

CERCOPITHECUS NICTITANS; GORILLA GORILLA; PAN; PAN TROGLODYTES TROGLODYTES; PRIMATES; RABBIT FIBROMA VIRUS; SIMIAN FOAMY VIRUS;

EID: 84870700235     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01715-12     Document Type: Article

References (81)

1. Betsem E, Rua R, Tortevoye P, Froment A, Gessain A. 2011. Frequent and recent human acquisition of simian foamy viruses through apes' bites in central Africa. PLoS Pathog. 7:e1002306. doi:10.1371/journal.ppat.1002306.
2. Boyer PL, Stenbak CR, Clark PK, Linial ML, Hughes SH. 2004. Characterization of the polymerase and RNase H activities of human foamy virus reverse transcriptase. J. Virol. 78:6112-6121.
3. Boyer PL, Stenbak CR, Hoberman D, Linial ML, Hughes SH. 2007. In vitro fidelity of the prototype primate foamy virus (PFV) RT compared to HIV-1 RT. Virology 367:253-264.
4. Brooks JI, et al. 2002. Cross-species retroviral transmission from macaques to human beings. Lancet 360:387-388.
5. Cain D, Erlwein O, Grigg A, Russell RA, McClure MO. 2001. Palindromic sequence plays a critical role in human foamy virus dimerization. J. Virol. 75:3731-3739.
6. Calattini S, et al. 2007. Simian foamy virus transmission from apes to humans, rural Cameroon. Emerg. Infect. Dis. 13:1314-1320.
7. Calattini S, et al. 2006. Detection and molecular characterization of foamy viruses in Central African chimpanzees of the Pan troglodytes troglodytes and Pan troglodytes vellerosus subspecies. J. Med. Primatol. 35:59-66.
8. Callahan ME, et al. May 2002. Retrovirus isolated from humans. Patent WO 0239116-A2 5.
9. Callahan ME, et al. 1999. Persistent zoonotic infection of a human with simian foamy virus in the absence of an intact orf-2 accessory gene. J. Virol. 73:9619-9624.
10. Campbell M, Eng C, Luciw PA. 1996. The simian foamy virus type 1 transcriptional transactivator (Tas) binds and activates an enhancer element in the gag gene. J. Virol. 70:6847-6855.
11. Campbell M, Renshaw-Gegg L, Renne R, Luciw PA. 1994. Characterization of the internal promoter of simian foamy viruses. J. Virol. 68:4811-4820.
12. Cartellieri M, et al. 2005. N-terminal Gag domain required for foamy virus particle assembly and export. J. Virol. 79:12464-12476.
13. Chang J, et al. 1995. Human foamy virus Bel1 transactivator contains a bipartite nuclear localization determinant which is sensitive to protein context and triple multimerization domains. J. Virol. 69:801-808.
14. De Celis-Kosmas J, Coronel A, Grigorian I, Emanoil-Ravier R, Tobaly-Tapiero J. 1997. Non-random deletions in human foamy virus long terminal repeat during viral infection. Arch. Virol. 142:1237-1246.
15. Delelis O, Lehmann-Che J, Saib A. 2004. Foamy viruses-a world apart. Curr. Opin. Microbiol. 7:400-406.
16. Duda A, et al. 2004. Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivity. J. Virol. 78:13865-13870.
17. Duffy S, Shackelton LA, Holmes EC. 2008. Rates of evolutionary change in viruses: patterns and determinants. Nat. Rev. Genet. 9:267-276.
18. Eastman SW, Linial ML. 2001. Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly. J. Virol. 75:6857-6864.
19. Enssle J, et al. 1997. Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle. J. Virol. 71:7312-7317.
20. Enssle J, et al. 1999. An active foamy virus integrase is required for virus replication. J. Gen. Virol. 80(Pt 6):1445-1452.
21. Erlwein O, Cain D, Fischer N, Rethwilm A, McClure MO. 1997. Identification of sites that act together to direct dimerization of human foamy virus RNA in vitro. Virology 229:251-258.
22. Falcone V, et al. 1999. Sites of simian foamy virus persistence in naturally infected African green monkeys: latent provirus is ubiquitous, whereas viral replication is restricted to the oral mucosa. Virology 257:7-14.
23. Flugel RM, Pfrepper KI. 2003. Proteolytic processing of foamy virus Gag and Pol proteins. Curr. Top. Microbiol. Immunol. 277:63-88.
24. Gartner K, et al. 2009. Accuracy estimation of foamy virus genome copying. Retrovirology 6:32. doi:10.1186/1742-4690-6-32.
25. Gessain A, Mahieux R. 2000. Epidemiology, origin and genetic diversity of HTLV-1 retrovirus and STLV-1 simian affiliated retrovirus. Bull. Soc. Pathol. Exot. 93:163-171. (In French.)
26. Giron ML, de The H, Saib A. 1998. An evolutionarily conserved splice generates a secreted Env-Bet fusion protein during human foamy virus infection. J. Virol. 72:4906-4910.
27. Goepfert PA, Wang G, Mulligan MJ. 1995. Identification of an ER retrieval signal in a retroviral glycoprotein. Cell 82:543-544.
28. Graham RL, Baric RS. 2010. Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission. J. Virol. 84:3134-3146.
29. He F, Blair WS, Fukushima J, Cullen BR. 1996. The human foamy virus Bel-1 transcription factor is a sequence-specific DNA binding protein. J. Virol. 70:3902-3908.
30. He F, Sun JD, Garrett ED, Cullen BR. 1993. Functional organization of the Bel-1 trans activator of human foamy virus. J. Virol. 67:1896-1904.
31. Heneine W, et al. 1998. Identification of a human population infected with simian foamy viruses. Nat. Med. 4:403-407.
32. Iturriza-Gomara M, Isherwood B, Desselberger U, Gray J. 2001. Reassortment in vivo: driving force for diversity of human rotavirus strains isolated in the United Kingdom between 1995 and 1999. J. Virol. 75:3696-3705.
33. Kang Y, Blair WS, Cullen BR. 1998. Identification and functional characterization of a high-affinity Bel-1 DNA binding site located in the human foamy virus internal promoter. J. Virol. 72:504-511.
34. Kang Y, Cullen BR. 1998. Derivation and functional characterization of a consensus DNA binding sequence for the Tas transcriptional activator of simian foamy virus type 1. J. Virol. 72:5502-5509.
35. Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. 2005. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu. Rev. Microbiol. 59:587-635.
36. Kupiec JJ, et al. 1988. Evidence for a gapped linear duplex DNA intermediate in the replicative cycle of human and simian spumaviruses. Nucleic Acids Res. 16:9557-9565.
37. Lee HS, Kang SY, Shin CG. 2005. Characterization of the functional domains of human foamy virus integrase using chimeric integrases. Mol. Cells 19:246-255.
38. Leendertz SA, et al. 2010. High prevalence, coinfection rate, and genetic diversity of retroviruses in wild red colobus monkeys (Piliocolobus badius badius) in Tai National Park, Cote d'Ivoire. J. Virol. 84:7427-7436.
39. Lindemann D, et al. 2001. A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. J. Virol. 75:5762-5771.
40. Lindemann D, Rethwilm A. 1998. Characterization of a human foamy virus 170-kilodalton Env-Bet fusion protein generated by alternative splicing. J. Virol. 72:4088-4094.
41. Lochelt M. 2003. Foamy virus transactivation and gene expression. Curr. Top. Microbiol. Immunol. 277:27-61.
42. Mahieux R, Gessain A. 2011. HTLV-3/STLV-3 and HTLV-4 viruses: discovery, epidemiology, serology and molecular aspects. Viruses 3:1074-1090.
43. Mannigel I, Stange A, Zentgraf H, Lindemann D. 2007. Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome. J. Virol. 81:3317-3326.
44. Matthes D, et al. 2011. Basic residues in the foamy virus Gag protein. J. Virol. 85:3986-3995.
45. Maurer B, Bannert H, Darai G, Flugel RM. 1988. Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus. J. Virol. 62:1590-1597.
46. Meiering CD, Linial ML. 2001. Historical perspective of foamy virus epidemiology and infection. Clin. Microbiol. Rev. 14:165-176.
47. Meiering CD, Linial ML. 2002. Reactivation of a complex retrovirus is controlled by a molecular switch and is inhibited by a viral protein. Proc. Natl. Acad. Sci. U. S. A. 99:15130-15135.
48. Mouinga-Ondeme A, et al. 2012. Cross-species transmission of simian foamy virus to humans in rural Gabon, Central Africa. J. Virol. 86:1255-1260.
49. Mullers E, et al. 2011. Novel functions of prototype foamy virus Gag glycine-arginine-rich boxes in reverse transcription and particle morphogenesis. J. Virol. 85:1452-1463.
50. Murray SM, Linial ML. 2006. Foamy virus infection in primates. J. Med. Primatol. 35:225-235.
51. Murray SM, et al. 2008. Replication in a superficial epithelial cell niche explains the lack of pathogenicity of primate foamy virus infections. J. Virol. 82:5981-5985.
52. Murray SM, Picker LJ, Axthelm MK, Linial ML. 2006. Expanded tissue targets for foamy virus replication with simian immunodeficiency virusinduced immunosuppression. J. Virol. 80:663-670.
53. Onafuwa-Nuga A, Telesnitsky A. 2009. The remarkable frequency of human immunodeficiency virus type 1 genetic recombination. Microbiol. Mol. Biol. Rev. 73:451-480.
54. Parrish CR, et al. 2008. Cross-species virus transmission and the emergence of new epidemic diseases. Microbiol. Mol. Biol. Rev. 72:457-470.
55. Parrish CR, Kawaoka Y. 2005. The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu. Rev. Microbiol. 59:553-586.
56. Peters C. 2007. Emerging viral diseases, p 605-626. In Knipe DM, et al(ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
57. Pfrepper KI, Lochelt M, Schnolzer M, Flugel RM. 1997. Expression and molecular characterization of an enzymatically active recombinant human spumaretrovirus protease. Biochem. Biophys. Res. Commun. 237:548-553.
58. Pietschmann T, Zentgraf H, Rethwilm A, Lindemann D. 2000. An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity. J. Virol. 74:4474-4482.
59. Rethwilm A. 1995. Regulation of foamy virus gene expression. Curr. Top. Microbiol. Immunol. 193:1-24.
60. Saib A. 2003. Non-primate foamy viruses. Curr. Top. Microbiol. Immunol. 277:197-211.
61. Saib A, et al. 1997. Long-term persistent infection of domestic rabbits by the human foamy virus. Virology 228:263-268.
62. Saib A, Peries J, de The H. 1993. A defective human foamy provirus generated by pregenome splicing. EMBO J. 12:4439-4444.
63. Sandstrom PA, et al. 2000. Simian foamy virus infection among zoo keepers. Lancet 355:551-552.
64. Schliephake AW, Rethwilm A. 1994. Nuclear localization of foamy virus Gag precursor protein. J. Virol. 68:4946-4954.
65. Schmidt M, Herchenroder O, Heeney J, Rethwilm A. 1997. Long terminal repeat U3 length polymorphism of human foamy virus. Virology 230:167-178.
66. Schulze A, et al. 2011. Complete nucleotide sequence and evolutionary analysis of a gorilla foamy virus. J. Gen. Virol. 92:582-586.
67. Schweizer M, et al. 1995. Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res. Hum. Retroviruses 11:161-170.
68. Shapshak P, Chiappelli F, Somboonwit C, Sinnott J. 2011. The influenza pandemic of 2009: lessons and implications. Mol. Diagn. Ther. 15:63-81.
69. Sharp PM, et al. 2001. The origins of acquired immune deficiency syndrome viruses: where and when? Philos. Trans. R. Soc. Lond. B Biol. Sci. 356:867-876.
70. Slattery JP, Franchini G, Gessain A. 1999. Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses. Genome Res. 9:525-540.
71. Stange A, et al. 2005. Characterization of prototype foamy virus gag late assembly domain motifs and their role in particle egress and infectivity. J. Virol. 79:5466-5476.
72. Switzer WM, et al. 2004. Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J. Virol. 78:2780-2789.
73. Switzer WM, et al. 2005. Ancient co-speciation of simian foamy viruses and primates. Nature 434:376-380.
74. Tobaly-Tapiero J, et al. 2001. Human foamy virus capsid formation requires an interaction domain in the N terminus of Gag. J. Virol. 75:4367-4375.
75. Webster RG, et al. 2005. The spread of the H5N1 bird flu epidemic in Asia in 2004. Arch. Virol. Suppl, p 117-129.
76. Winkler IG, Lochelt M, Flower RL. 1999. Epidemiology of feline foamy virus and feline immunodeficiency virus infections in domestic and feral cats: a seroepidemiological study. J. Clin. Microbiol. 37:2848-2851.
77. Wolfe ND, et al. 2004. Naturally acquired simian retrovirus infections in central African hunters. Lancet 363:932-937.
78. Yu SF, et al. 1996. The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains. J. Virol. 70:8255-8262.
79. Yu SF, Stone J, Linial ML. 1996. Productive persistent infection of hematopoietic cells by human foamy virus. J. Virol. 70:1250-1254.
80. Zemba M, et al. 1998. The carboxy-terminal p3Gag domain of the human foamy virus Gag precursor is required for efficient virus infectivity. Virology 247:7-13.
81. Zou JX, Luciw PA. 1996. The transcriptional transactivator of simian foamy virus 1 binds to a DNA target element in the viral internal promoter. Proc. Natl. Acad. Sci. U. S. A. 93:326-330.